About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 676 record(s)
Req # A-2023-000276
All records relating to registered lobbying communication #510223 involving Christopher Johnstone, Assistant Deputy Minister, Health Canada (HC) and Amazon Canada Fulfillment Services, ULC on June 08, 2021. All records relating to registered…Organization: Health Canada
August 2023
Req # A-2023-000314
All documents and correspondence which the rapid test supplier BTNX, Inc., submitted to Health Canada as it applied for approval to sell the COVID-19 antigen test with the device identifier COV-19C25.Timeframe: Sept. 1, 2020 through March 31, 2021.Organization: Health Canada
August 2023
Req # A-2023-000373
How many persons are working in the Biologic and Radiopharmaceutical Drugs Directorate that are over age 70 at present?, How many persons are working in the Biologic and Radiopharmaceutical Drugs Directorate that are over age 75 at present?, How…Organization: Health Canada
August 2023
Req # A-2023-000403
The Health Canada and Manufacturer corresponding covering letters only for the submission supporting the Administrative Change in Product Ownership for: Manufacturer: Essential Pharma Switzerland GMBH BRAND: IOPIDINE DIN: 00888354 and 02076306.Organization: Health Canada
August 2023
Req # A-2023-000481
All records between Canadian not-for-profit "Dying with Dignity Canada" and Health Canada officials between January 19, 2023 and July 7, 2023.Organization: Health Canada
August 2023
Req # A-2023-000530
Information regarding cefiderocol. Number of Special Access Program (SAP) requests since start of the program and number of approvals granted by Health Canada. Physicians/hospitals who requested cefiderocol via SAP. Cefiderocol SAP selling price in…Organization: Health Canada
August 2023
Req # A-2020-001442
Adverse Drug Reactions (ADRs) for DOCETAXEL. Report numbers: 736244, 736593, 737466, 737723, 737770, 908457, 908612, 909033, 910196, 910251, 910258, 911032, 911502, 911813, 912262.Organization: Health Canada
August 2023
Req # A-2020-001804
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-106853-419.Organization: Health Canada
August 2023
Req # A-2021-000424
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-102006-568.Organization: Health Canada
August 2023
Req # A-2021-002129
Adverse Drug Reactions (ADRs) for METRONIDAZOLE, IRBESARTAN. Report numbers: E2B_04927112, 000972078, 000972569, 000972665, 000972188.Organization: Health Canada
August 2023